SCHEMBL2480966

SCHEMBL2480966

CCCCCCCCCCCCC(=S)OCC(COC(=S)CCCCCCCCCCCC)(COC(=S)CCCCCCCCCCCC)COC(=S)CCCCCCCCCCCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.41
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
CES2 O00748 3/20 0.38
CES1 P23141 3/20 0.38
PAM P19021 2/20 0.37
GPR84 Q9NQS5 7/20 0.37
PPARG P37231 6/20 0.37
PPARD Q03181 6/20 0.37
PPARA Q07869 6/20 0.37
HDAC11 Q96DB2 5/20 0.37
TSHR P16473 4/20 0.37
ALDH1A1 P00352 2/20 0.37
TLR2 O60603 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
FABP4 P15090 2/20 0.37
PTPN1 P18031 2/20 0.37
SLC22A6 Q4U2R8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5445243 1.00 DGKA (0.41) DGKACA12CA1CA2CA9
SCHEMBL2482373 1.00 DGKA (0.41) DGKACA12CA1CA2CA9
SCHEMBL2481095 1.00 DGKA (0.41) DGKACA12CA1CA2CA9
SCHEMBL2480943 1.00 DGKA (0.41) DGKACA12CA1CA2CA9
SCHEMBL2483618 1.00 DGKA (0.41) DGKACA12CA1CA2CA9
SCHEMBL2483072 1.00 DGKA (0.41) DGKACA12CA1CA2CA9
SCHEMBL812389 1.00 DGKA (0.41) DGKACA12CA1CA2CA9
SCHEMBL811803 1.00 DGKA (0.41) DGKACA12CA1CA2CA9
SCHEMBL2481893 1.00 DGKA (0.41) DGKACA12CA1CA2CA9
SCHEMBL2483071 1.00 DGKA (0.41) DGKACA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250074860-A1 INTRAMOLECULAR COMPLEX HINDERED PHENOL COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF RIANLON CORPORATION (CN) 2025-03-06 US disclosed
EP-1947725-B1 Polymer electrolyte composition and fuel cell SUMITOMO CHEMICAL CO (JP) 2011-10-19 EP disclosed
EP-1947725-A2 Polymer electrolyte composition and fuel cell Sumitomo Chemical Company, Limited (JP) 2008-07-23 EP disclosed
EP-1289041-B1 Polymer electrolyte composition and fuel cell SUMITOMO CHEMICAL CO (JP) 2008-03-12 EP disclosed
US-20060257706-A1 POLYMER ELECTROLYTE COMPOSITION AND FUEL CELL HIDAKA YASUAKI 2006-11-16 US disclosed
US-20030113605-A1 Polymer electrolyte composition and fuel cell SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-06-19 US disclosed
EP-1289041-A2 Polymer electrolyte composition and fuel cell SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-03-05 EP disclosed
EP-0416321-B1 Crystalline polyolefin composition CHISSO CORP (JP) 1994-11-09 EP disclosed
US-5063264-A Molding materials CHISSO CORPORATION (JP) 1991-11-05 US disclosed
EP-0416321-A1 Crystalline polyolefin composition Chisso Corporation (JP) 1991-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250074860-A1 INTRAMOLECULAR COMPLEX HINDERED PHENOL COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF NOX1, NOX4, CYP4F11 DGKA 4592/4885CA12 4291/4885CA1 3963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.